Retraction Note: Letter to Editor, “The effects of dabrafenib and/or trametinib treatment in Braf V600mutant glioma: a systematic review and metaanalysis”

被引:0
|
作者
Hethesh Chellapandian [1 ]
Sivakamavalli Jeyachandran [1 ]
机构
[1] Saveetha Dental College and Hospital,Lab in Biotechnology and Biosignal Transduction, Department of Orthodontics
[2] Saveetha Institute of Medical and Technical Sciences (SIMATS),undefined
关键词
D O I
10.1007/s10143-025-03284-9
中图分类号
学科分类号
摘要
引用
下载
收藏
相关论文
共 50 条
  • [11] SAFETY AND EFFICACY OF DUAL THERAPY WITH DABRAFENIB AND TRAMETINIB IN AN INFANT WITH BRAF V600E MUTANT INOPERABLE LOW GRADE GLIOMA
    Green, Sage
    Walter, Andrew
    Piatt, Joseph
    Kaur, Gurcharanjeet
    NEURO-ONCOLOGY, 2021, 23 : 34 - 34
  • [12] Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma
    Hargrave, Darren R.
    Terashima, Keita
    Hara, Junichi
    Kordes, Uwe R.
    Upadhyaya, Santhosh A.
    Sahm, Felix
    Bouffet, Eric
    Packer, Roger J.
    Witt, Olaf
    Sandalic, Larissa
    Kieloch, Agnieszka
    Russo, Mark
    Cohen, Kenneth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5174 - +
  • [13] Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG).
    Subbiah, Vivek
    Stein, Alexander
    van den Bent, Martin
    Wick, Antje
    de Vos, Filip Y.
    von Bubnoff, Nikolas
    van Linde, Myra E.
    Lai, Albert
    Prager, Gerald W.
    Campone, Mario
    Fasolo, Angelica
    Lopez-Martin, Jose A.
    Kim, Tae Min
    Hofheinz, Ralf-Dieter
    Blay, Jean-Yves
    Cho, Daniel C.
    Gazzah, Anas
    Pouessel, Damien
    Yachnin, Jeffrey
    Boran, Aislyn
    Burgess, Paul
    Ilankumaran, Palanichamy
    Gasal, Eduard
    Wen, Patrick Y.
    CANCER RESEARCH, 2021, 81 (13)
  • [14] Successful Treatment with Dabrafenib/Trametinib of a Malignantly Transformed and Metastasized BRAF V600E Mutant Pleiomorphic Xanthoastrocytoma: A Case Report and Review of the Literature
    Vermeulen, Elle
    Vander Mijnsbrugge, An-Sofie
    Brock, Stefanie
    Vaeyens, Freya
    Dirven, Iris
    Cicek, Abdulhamid
    Marcelis, William
    Klein, Samuel
    Bruneau, Michael
    Neyns, Bart
    Duerinck, Johnny
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 10 - 16
  • [15] Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib
    Jansen, Yanina J.
    Janssens, Peter
    Hoorens, Anne
    Schreuer, Max S.
    Seremet, Teofila
    Wilgenhof, Sofie
    Neyns, Bart
    MELANOMA RESEARCH, 2015, 25 (06) : 550 - 554
  • [16] Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC
    Planchard, David
    Besse, Benjamin
    Groen, Harry J. M.
    Hashemi, Sayed M. S.
    Mazieres, Julien
    Kim, Tae Min
    Quoix, Elisabeth
    Souquet, Pierre-Jean
    Barlesi, Fabrice
    Baik, Christina
    Villaruz, Liza C.
    Kelly, Ronan J.
    Zhang, Shirong
    Tan, Monique
    Gasal, Eduard
    Santarpia, Libero
    Johnson, Bruce E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (01) : 103 - 115
  • [17] Dabrafenib plus trametinib combination therapy in pediatric patients with BRAF V600-mutant low-grade glioma: Safety and efficacy results.
    Geoerger, Birgit
    Bouffet, Eric
    Whitlock, James A.
    Moertel, Christopher L.
    Hargrave, Darren R.
    Aerts, Isabelle
    Cohen, Kenneth J.
    Kilburn, Lindsay Baker
    Wright, Karen D.
    Choi, Jeea
    Gasal, Eduard
    Russo, Mark W.
    Fox, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [18] Complete response of metastatic BRAF V600-mutant anaplastic thyroid cancer following adjuvant dabrafenib and trametinib treatment: A case report
    Lee, Sang Jae
    Song, Si-Youn
    Kim, Min Kyoung
    Na, Hyung Gyun
    Bae, Chang Hoon
    Kim, Yong-Dae
    Choi, Yoon Seok
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (27) : 6664 - 6669
  • [19] Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real World Setting
    Auliac, J. B.
    Bayle, S.
    Do, P.
    Legarff, G.
    Guisier, F.
    Roa, M.
    Falchero, L.
    Huchon, E.
    Quere, G.
    Jeannin, G.
    Doubre, H.
    Baud, M.
    Hobeika, J.
    Chouaid, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S857 - S857
  • [20] Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
    Long, Georgina V.
    Weber, Jeffrey S.
    Infante, Jeffrey R.
    Kim, Kevin B.
    Daud, Adil
    Gonzalez, Rene
    Sosman, Jeffrey A.
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Kefford, Richard F.
    Lawrence, Donald
    Kudchadkar, Ragini
    Burris, Howard A., III
    Falchook, Gerald S.
    Algazi, Alain
    Lewis, Karl
    Puzanov, Igor
    Ibrahim, Nageatte
    Sun, Peng
    Cunningham, Elizabeth
    Kline, Amy S.
    Buono, HeatherDel
    OpattMcDowell, Diane
    Patel, Kiran
    Flaherty, Keith T.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (08) : 871 - +